Literature DB >> 11086053

Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.

J L Cannons1, Y Choi, T H Watts.   

Abstract

4-1BB is a costimulatory member of the TNFR family, expressed on activated CD4(+) and CD8(+) T cells. Previous results showed that 4-1BB-mediated T cell costimulation is CD28-independent and involves recruitment of TNFR-associated factor 2 (TRAF2) and activation of the stress-activated protein kinase cascade. Here we describe a role for the p38 mitogen-activated protein kinase (MAPK) pathway in 4-1BB signaling. Aggregation of 4-1BB alone induces p38 activation in a T cell hybridoma, whereas, in normal T cells, p38 MAPK is activated synergistically by immobilized anti-CD3 plus immobilized 4-1BB ligand. 4-1BB-induced p38 MAPK activation is inhibited by the p38-specific inhibitor SB203580 in both a T cell hybridoma and in murine T cells. T cells from TRAF2 dominant-negative mice are impaired in 4-1BB-mediated p38 MAPK activation. A link between TRAF2 and the p38 cascade is provided by the MAPK kinase kinase, apoptosis-signal-regulating kinase 1. A T cell hybrid transfected with a kinase-dead apoptosis-signal-regulating kinase 1 fails to activate p38 MAPK in response to 4-1BB signaling. To assess the role of p38 activation in an immune response, T cells were stimulated in an MLR in the presence of SB203580. In a primary MLR, SB203580 blocked IL-2, IFN-gamma, and IL-4 secretion whether the costimulatory signal was delivered via 4-1BB or CD28. In contrast, following differentiation into Th1 or Th2 cells, p38 inhibition blocked IL-2 and IFN-gamma without affecting IL-4 secretion. Nevertheless, IL-4 secretion by Th2 cells remained costimulation-dependent. Thus, critical T cell signaling events diverge following Th1 vs Th2 differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086053     DOI: 10.4049/jimmunol.165.11.6193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.

Authors:  Yuwen Zhu; Gefeng Zhu; Liqun Luo; Andrew S Flies; Lieping Chen
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

2.  The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death.

Authors:  Seung-Joo Lee; Meixiao Long; Adam J Adler; Robert S Mittler; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2008-10-15       Impact factor: 4.962

3.  Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.

Authors:  Ann J McPherson; Laura M Snell; Tak W Mak; Tania H Watts
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

4.  Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.

Authors:  Kuang Youlin; Zhang Li; Gou Xin; Xiao Mingchao; Liu Xiuheng; Weng Xiaodong
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

5.  Effects of 4-1BB signaling on the biological function of murine dendritic cells.

Authors:  Youlin Kuang; Xiaodong Weng; Xiuheng Liu; Hengchen Zhu; Zhiyuan Chen; Hui Chen
Journal:  Oncol Lett       Date:  2011-12-01       Impact factor: 2.967

6.  Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Authors:  Arantza Azpilikueta; Elixabet Bolaños; Valerie Lang; Sara Labiano; Maria A Aznar; Iñaki Etxeberria; Alvaro Teijeira; Maria E Rodriguez-Ruiz; Jose L Perez-Gracia; Maria Jure-Kunkel; Juan M Zapata; Manuel S Rodriguez; Ignacio Melero
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

7.  CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.

Authors:  Matthew H Forsberg; Ashley E Ciecko; Kyle J Bednar; Arata Itoh; Kritika Kachapati; William M Ridgway; Yi-Guang Chen
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 8.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

9.  Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.

Authors:  Guoqiang Li; Xiaofeng Wu; Feng Zhang; Xiangcheng Li; Beicheng Sun; Yue Yu; Aihong Yin; Lei Deng; Jie Yin; Xuehao Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-19       Impact factor: 4.553

Review 10.  The role of TNF superfamily members in T-cell function and diseases.

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.